LRP4 is critical for neuromuscular junction maintenance

Journal of Neuroscience

Volumn 34, Issue 42, 2014, Pages 13892-13905

  Barik, Arnab ^a   Lu, Yisheng ^a   Sathyamurthy, Anupama ^a   Bowman, Andrew ^a   Shen, Chengyong ^a   Li, Lei ^a   Xiong, Wen Cheng ^a,b   Mei, Lin ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AChRs; Agrin; Congenital myasthenic syndrome; LRP4; NMJ; Synaptic basal lamina

Indexed keywords

AGRIN; ALPHA DYSTROGLYCAN; CHOLINERGIC RECEPTOR; DOXYCYCLINE; FASCICULIN; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4; NEUROFILAMENT PROTEIN; PROTEIN S100B; PROTEIN TYROSINE KINASE; RAPSYN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; UTROPHIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LRP4 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONGENITAL MYASTHENIC SYNDROME; CONTROLLED STUDY; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; ENDPLATE POTENTIAL; GASTROCNEMIUS MUSCLE; GENE MUTATION; INTRACELLULAR SIGNALING; MALE; MOTONEURON; MOUSE; MUSCLE CONTRACTION; MUSCLE STRENGTH; MYASTHENIA GRAVIS; NERVE STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMUSCULAR FACILITATION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; QUANTITATIVE ANALYSIS; SCHWANN CELL; STIMULUS RESPONSE; SYNAPSE VESICLE; SYNAPTIC POTENTIAL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DEFICIENCY; HUMAN; KNOCKOUT MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROMUSCULAR JUNCTION; RECEPTORS, LDL;

EID: 84907990987     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1733-14.2014     Document Type: Article

References (126)

1. Ahn Y, Sims C, Logue JM, Weatherbee SD, Krumlauf R (2013) Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling. Development 140:583–593.
2. Akaaboune M, Allinquant B, Farza H, Roy K, Magoul R, Fiszman M, Festoff BW, Hantaï D (2000) Developmental regulation of amyloid precursor proteinat the neuromuscular junction in mouse skeletal muscle. Mol Cell Neurosci 15:355–367.
3. Annies M, Bittcher G, Ramseger R, Löschinger J, Wöll S, Porten E, Abraham C, Rüegg MA, Kröger S (2006) Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Mol Cell Neurosci 31:515–524.
4. Banks GB, Fuhrer C, Adams ME, Froehner SC (2003) The postsynaptic sub-membrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex. J Neurocytol 32:709–726.
5. Barik A, Xiong Wc, Mei L (2012) MuSK: a kinase critical for the formation and maintenance of the neuromuscular junction. In: Protein kinase technologies, vol. 68 (Mukai H, ed.), pp 203–217.
6. Barik A, Zhang B, Sohal GS, Xiong WC, Mei L (2014) Crosstalk between Agrin and Wnt signaling pathways in development of vertebrate neuro-muscular junction. Dev Neurobiol 74:828–838.
7. Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M, Müller JS, Lochmüller H, Slater C, Vincent A, Yamanashi Y (2006) Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313:1975–1978.
8. Ben Ammar A, Soltanzadeh P, Bauche´ S, Richard P, Goillot E, Herbst R, Gaudon K, Huze´ C, Schaeffer L, Yamanashi Y, Higuchi O, Taly A, Koenig J, Leroy JP, Hentati F, Najmabadi H, Kahrizi K, Ilkhani M, Fardeau M, Eymard B, et al. (2013) A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia. PLoS One 8:e53826.
9. Bezakova G, Ruegg MA (2003) New insights into the roles of agrin. Nat Rev Mol Cell Biol 4:295–308.
10. Bezakova G, Rabben I, Sefland I, Fumagalli G, Lømo T (2001) Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers. Proc Natl Acad Sci USA 98:9924–9929.
11. Blake DJ, Tinsley JM, Davies KE (1994) The emerging family of dystrophin-related proteins. Trends Cell Biol 4:19–23.
12. Bogdanik LP, Burgess RW (2011) A valid mouse model of AGRIN-associated congenital myasthenic syndrome. Hum Mol Genet 20:4617– 4633.
13. Bolliger MF, Zurlinden A, Lüscher D, Bütikofer L, Shakhova O, Francolini M, Kozlov SV, Cinelli P, Stephan A, Kistler AD, Rülicke T, Pelczar P, Leder-mann B, Fumagalli G, Gloor SM, Kunz B, Sonderegger P (2010) Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J Cell Sci 123:3944–3955.
14. Boudin E, Steenackers E, de Freitas F, Nielsen TL, Andersen M, Brixen K, Van Hul W, Piters E (2013) A common LRP4 haplotype is associated with bone mineral density and hip geometry in men: data from the Odense Androgen Study (OAS). Bone 53:414–420.
15. Bowe MA, Deyst KA, Leszyk JD, Fallon JR (1994) Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex relatedto the dystroglycans. Neuron 12:1173–1180.
16. Brenner HR, Herczeg A, Slater CR (1992) Synapse-specific expression of acetylcholine receptor genes and their products at original synaptic sites in rat soleus muscle fibres regenerating in the absence of innervation. Development 116:41–53.
17. Brenner HR, Akaaboune M (2014) Recycling of acetylcholine receptors at ectopic postsynaptic clusters induced by exogenous agrin in living rats. Dev Biol. Advance online publication. Retrieved Aug. 4, 2014. doi: 10.1016/j.ydbio.2014.07.018.
18. Burgess RW, Nguyen QT, Son YJ, Lichtman JW, Sanes JR (1999) Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 23:33–44.
19. Burgess RW, Skarnes WC, Sanes JR (2000) Agrin isoforms with distinct amino termini: differential expression, localization, and function. J Cell Biol 151:41–52.
20. Campanelli JT, Roberds SL, Campbell KP, Scheller RH (1994) A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77:663–674.
21. Chevessier F, Girard E, Molgö J, Bartling S, Koenig J, Hantaï D, Witzemann V (2008) A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromus-cular junctions. Hum Mol Genet 17:3577–3595.
22. Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930.
23. Choi HY, Liu Y, Tennert C, Sugiura Y, Karakatsani A, Kröger S, Johnson EB, Hammer RE, Lin W, Herz J (2013) APP interacts with LRP4 and agrin to coordinate the development of the neuromuscular junction in mice. Elife 2:e00220.
24. Coˆte´ PD, Moukhles H, Lindenbaum M, Carbonetto S (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23:338–342.
25. Culican SM, Nelson CC, Lichtman JW (1998) Axon withdrawal during synapse elimination at the neuromuscular junction is accompanied by disassembly of the postsynaptic specialization and withdrawal of Schwann cell processes. J Neurosci 18:4953–4965.
26. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501–512.
27. Denzer AJ, Brandenberger R, Gesemann M, Chiquet M, Ruegg MA (1997) Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol 137:671–683.
28. Durbeej M, Henry MD, Campbell KP (1998) Dystroglycan in development and disease. Curr Opin Cell Biol 10:594–601.
29. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystro-phic muscle. Nature 345:315–319.
30. Eusebio A, Oliveri F, Barzaghi P, Ruegg MA (2003) Expression of mouse agrininnormal, denervated and dystrophic muscle. Neuromuscul Disord 13:408–415.
31. Fallon JR, Hall ZW (1994) Building synapses: agrin and dystroglycan stick together. Trends Neurosci 17:469–473.
32. Feng Z, Ko CP (2008) The role of glial cells in the formation and maintenance of the neuromuscular junction. Ann N Y Acad Sci 1132:19–28.
33. 125I-alpha-bungarotoxin binding at mouse neuromuscular junctions. J Cell Biol 69:144–158.
34. Friese MB, Blagden CS, Burden SJ (2007) Synaptic differentiation is defective in mice lacking acetylcholine receptor beta-subunit tyrosine phos-phorylation. Development 134:4167–4176.
35. 2+ exchanger increases post-tetanic evoked release. J Physiol 574:663–675.
36. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, Sanes JR (1996) Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85:525–535.
37. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S (1994) Dystroglycan-a, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77:675–686.
38. Gesemann M, Denzer AJ, Ruegg MA (1995) Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site. J Cell Biol 128:625–636.
39. Gesemann M, Cavalli V, Denzer AJ, Brancaccio A, Schumacher B, Ruegg MA (1996) Alternative splicing of agrin alters its binding to heparin, dystro- glycan, and the putative agrin receptor. Neuron 16:755–767.
40. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM, Yancopoulos GD (1996) Agrin acts via a MuSK receptor complex. Cell 85:513–523.
41. Gordon LR, Gribble KD, Syrett CM, Granato M (2012) Initiation of synapse formation by Wnt-induced MuSK endocytosis. Development 139:1023-1033.
42. Grady RM, Akaaboune M, Cohen AL, Maimone MM, Lichtman JW, Sanes JR (2003) Tyrosine-phosphorylated and nonphosphorylated isoforms of a-dystrobrevin: roles in skeletal muscle and its neuromuscular and myo-tendinous junctions. J Cell Biol 160:741–752.
43. Hamuro J, Higuchi O, Okada K, Ueno M, Iemura S, Natsume T, Spearman H, Beeson D, Yamanashi Y (2008) Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem 283:5518-5524.
44. Henriquez JP, Webb A, Bence M, Bildsoe H, Sahores M, Hughes SM, Salinas PC (2008). Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc Natl Acad Sci USA 105:18812–18817.
45. Herczeg A, Jones G, Brenner HR (1995) Involvement of extracellular matrix in acetylcholine receptor e-subunit gene expression at the rat neuromuscular junction. Neurosci Lett 193:33–36.
46. Hesser BA, Henschel O, Witzemann V (2006) Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactiva-tion of MuSK. Mol Cell Neurosci 31:470–480.
47. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365–368.
48. Huijbers MG, Zhang W, Klooster R, Niks EH, Friese MB, Straasheijm KR, Thijssen PE, Vrolijk H, Plomp JJ, Vogels P, Losen M, Van der Maarel SM, Burden SJ, Verschuuren JJ (2013) MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci USA 110:20783–20788.
49. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696–702.
50. Jing L, Lefebvre JL, Gordon LR, Granato M (2009) Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/ MuSK receptor. Neuron 61:721–733.
51. Jing L, Gordon LR, Shtibin E, Granato M (2010) Temporal and spatial requirements of unplugged/MuSK function during zebrafish neuromuscular development. PLoS One 5:e8843.
52. Jo SA, Burden SJ (1992) Synaptic basal lamina contains a signal for synapse-specific transcription. Development 115:673–680.
53. Johnson EB, Hammer RE, Herz J (2005) Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14:3523–3538.
54. Jones G, Meier T, Lichtsteiner M, Witzemann V, Sakmann B, Brenner HR (1997) Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle. Proc Natl Acad Sci USA 94:2654-2659.
55. Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML, Burden SJ (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135:334–342.
56. Kraner S, Laufenberg I, Strassburg HM, Sieb JP, Steinlein OK (2003) Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation. Arch Neurol 60:761–763.
57. Lefebvre JL, Jing L, Becaficco S, Franzini-Armstrong C, Granato M (2007) Differential requirement for MuSK and dystroglycan in generating patterns of neuromuscular innervation. Proc Natl Acad Sci USA 104:2483-2488.
58. Li XM, Dong XP, Luo SW, Zhang B, Lee DH, Ting AK, Neiswender H, Kim CH, Carpenter-Hyland E, Gao TM, Xiong WC, Mei L (2008) Retrograde regulation of motoneuron differentiation by muscle /3-catenin. Nat Neurosci 11:262–268.
59. Li Y, Pawlik B, Elcioglu N, Aglan M, Kayserili H, Yigit G, Percin F, Goodman F, Nürnberg G, Cenani A, Urquhart J, Chung BD, Ismail S, Amr K, Aslanger AD, Becker C, Netzer C, Scambler P, Eyaid W, Hamamy H, et al. (2010) LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani–Lenz syndrome. Am J Hum Genet 86:696–706.
60. Lin S, Maj M, Bezakova G, Magyar JP, Brenner HR, Ruegg MA (2008) Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice. Proc Natl Acad Sci USA 105:11406–11411.
61. Lin W, Burgess RW, Dominguez B, Pfaff SL, Sanes JR, Lee KF (2001) Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410:1057–1064.
62. Liu Y, Sugiura Y, Wu F, Mi W, Taketo MM, Cannon S, Carroll T, Lin W (2012) jS-Catenin stabilization in skeletal muscles, but not in motor neurons, leads to aberrant motor innervation of the muscle during neuromuscular development in mice. Dev Biol 366:255–267.
63. Luo S, Zhang B, Dong XP, Tao Y, Ting A, Zhou Z, Meixiong J, Luo J, Chiu FC, Xiong WC, Mei L (2008) HSP90 beta regulates rapsyn turnover and subsequent AChR cluster formation and maintenance. Neuron 60:97-110.
64. Luo ZG, Wang Q, Zhou JZ, Wang J, Luo Z, Liu M, He X, Wynshaw-Boris A, Xiong WC, Lu B, Mei L (2002) Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1. Neuron 35:489–505.
65. Marques MJ, Conchello JA, Lichtman JW (2000) From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J Neurosci 20:3663–3675.
66. Martin PT, Sanes JR (1997) Integrins mediate adhesion to agrin and modulate agrin signaling. Development 124:3909–3917.
67. Martinez-Pena Valenzuela I, Mouslim C, Pires-Oliveira M, Adams ME, Froehner SC, Akaaboune M (2011) Nicotinic acetylcholine receptor stability at the NMJ deficient in a-syntrophinin vivo. J Neurosci 31:15586-15596.
68. Maselli RA, Arredondo J, Cagney O, Ng JJ, Anderson JA, Williams C, Gerke BJ, Soliven B, Wollmann RL (2010) Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. Hum Mol Genet 19:2370–2379.
69. Maselli RA, Fernandez JM, Arredondo J, Navarro C, Ngo M, Beeson D, Cagney O, Williams DC, Wollmann RL, Yarov-Yarovoy V, Ferns MJ (2012) LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. Hum Genet 131:1123–1135.
70. Matthews-Bellinger JA, Salpeter MM (1983) Fine structural distribution of acetylcholine receptors at developing mouse neuromuscular junctions. J Neurosci 3:644–657.
71. McMahan UJ (1990) The agrin hypothesis. Cold Spring Harbor Symp Quant Biol 55:407–418.
72. Meier T, Gesemann M, Cavalli V, Ruegg MA, Wallace BG (1996) AChR phosphorylation and aggregation induced by an agrin fragment that lacks the binding domain for a-dystroglycan. EMBO J 15:2625–2631.
73. Meier T, Hauser DM, Chiquet M, Landmann L, Ruegg MA, Brenner HR (1997) Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers. J Neurosci 17:6534–6544.
74. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, Engvall E, Müller U, Ruegg MA (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413:302–307.
75. Moransard M, Borges LS, Willmann R, Marangi PA, Brenner HR, Ferns MJ, Fuhrer C (2003) Agrin regulates rapsyn interaction with surface acetyl-choline receptors, and this underlies cytoskeletal anchoring and clustering. J Biol Chem 27:7350–7359.
76. Müller JS, Abicht A, Christen HJ, Stucka R, Schara U, Mortier W, Huebner A, Lochmüller H (2004) A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome. Neuromuscul Disord 14:744–749.
77. Müller JS, Baumeister SK, Rasic VM, Krause S, Todorovic S, Kugler K, Müller-Felber W, Abicht A, Lochmüller H (2006) Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations. Neurology 67:1159–1164.
78. Neumann FR, Bittcher G, Annies M, Schumacher B, Kroger S, Ruegg MA (2001) An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Mol Cell Neurosci 17:208–225.
79. Nykjaer A, Willnow TE (2002) The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol 12:273–280.
80. Ohazama A, Porntaveetus T, Ota MS, Herz J, Sharpe PT (2010) Lrp4: a novel modulator of extracellular signaling in craniofacial organogenesis. Am J Med Genet A 152:2974–2983.
81. Ohkawara B, Cabrera-Serrano M, Nakata T, Milone M, Asai N, Ito K, Ito M, Masuda A, Ito Y, Engel AG, Ohno K (2014) LRP4 third /3-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner. Hum Mol Genet 23:1856–1868.
82. Ohlendieck K, Campbell KP (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115:1685-1694.
83. Patton BL, Cunningham JM, Thyboll J, Kortesmaa J, Westerblad H, Edstrom L, Tryggvason K, Sanes JR (2001) Properly formed but improperly localized synaptic specializations in the absence of laminin a4. Nat Neurosci 4:597–604.
84. Peng HB, Xie H, Rossi SG, Rotundo RL (1999) Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145:911–921.
85. Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kroger S (2012) Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259:427–435.
86. Pinson KI, Brennan J, Monkley S, Avery BJ, and Skarnes WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407:535–538.
87. Porter CW, Barnard EA (1976) Ultrastructural studies on the acetylcholine receptor at motor end plates of normal and pathologic muscles. Ann N Y Acad Sci 274:85–107.
88. Punga AR, Lin S, Oliveri F, Meinen S, Rüegg MA (2011) Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice. Exp Neurol 230:207–217.
89. Ramseger R, White R, Kroger S (2009) Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK. J Biol Chem 284:7697–7705.
90. Rao P, Monks DA (2009) A tetracycline-inducible and skeletal muscle-specific Cre recombinase transgenic mouse. DevNeurobiol 69:401–406.
91. Rasi S, Spina V, Bruscaggin A, Vaisitti T, Tripodo C, Forconi F, De Paoli L, Fangazio M, Sozzi E, Cencini E, Laurenti L, Marasca R, Visco C, Xu-Monette ZY, Gattei V, Young KH, Malavasi F, Deaglio S, Gaidano G, Rossi D (2011) A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 152:284–294.
92. Reif R, Sales S, Hettwer S, Dreier B, Gisler C, Wolfel J, Lüscher D, Zurlinden A, Stephan A, Ahmed S, Baici A, Ledermann B, Kunz B, Sonderegger P (2007) Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J 21:3468–3478.
93. Rotundo RL, Ruiz CA, Marrero E, Kimbell LM, Rossi SG, Rosenberry T, Darr A, Tsoulfas P (2008) Assembly and regulation of acetylcholinesterase at the vertebrate neuromuscular junction. Chem Biol Interact 175:26–29.
94. Ruegg MA, Tsim KW, Horton SE, Kroger S, Escher G, Gensch EM, McMahan UJ (1992) The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron 8:691–699.
95. Samuel MA, Valdez G, Tapia JC, Lichtman JW, Sanes JR (2012) Agrin and synaptic laminin are required to maintain adult neuromuscular junctions. PLoS One 7:e46663.
96. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60: 1978–1980.
97. Sanes JR, Lichtman JW (2001) Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2:791–805.
98. Schwander M, Shirasaki R, Pfaff SL, Müller U (2004) Beta1 integrins in muscle, but not in motor neurons, are required for skeletal muscle inner-vation. J Neurosci 24:8181–8191.
99. Shen C, Lu Y, Zhang B, Figueiredo D, Bean J, Jung J, Wu H, Barik A, Yin DM, Xiong WC, Mei L (2013) Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest 123: 5190–5202.
100. Shi L, Fu AK, Ip NY (2012) Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction. Trends Neu-rosci 35:441–453.
101. Shigemoto K, Kubo S, Maruyama N, Hato N, Yamada H, Jie C, Kobayashi N, Mominoki K, Abe Y, Ueda N, Matsuda S (2006) Induction of myasthe-nia by immunization against muscle-specific kinase. J Clin Invest 116: 1016–1024.
102. Shigemoto K, Kubo S, Jie C, Hato N, Abe Y, Ueda N, Kobayashi N, Kameda K, Mominoki K, Miyazawa A, Ishigami A, Matsude S, Maruyama N (2008) Myasthenia gravis experimentally induced with muscle-specific kinase. Ann N Y Acad Sci 1132:93–98.
103. Sohal GS (1995) Sixth Annual Stuart Reiner Memorial Lecture: embryonic development of nerve and muscle. Muscle Nerve 18:2–14.
104. Son YJ, Thompson WJ (1995a) Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron 14:133–141.
105. Son YJ, Thompson WJ (1995b) Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125–132.
106. Strochlic L, Falk J, Goillot E, Sigoillot S, Bourgeois F, Delers P, Rouvière J, Swain A, Castellani V, Schaeffer L, Legay C (2012) Wnt4 participates in the formation ofvertebrate neuromuscular junction. PLoS One 7:e29976.
107. Sugiyama J, Bowen DC, Hall ZW (1994) Dystroglycan binds nerve and muscle agrin. Neuron 13:103–115.
108. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530–535.
109. Thayer SA, Miller RJ (1990) Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J Physiol 425:85–115.
110. Wakui K, Gregato G, Ballif BC, Glotzbach CD, Bailey KA, Kuo PL, Sue WC, Sheffield LJ, Irons M, Gomez EG, Hecht JT, Potocki L, Shaffer LG (2005) Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndrome. Eur J Hum Genet 13:528–540.
111. Wang J, Jing Z, Zhang L, Zhou G, Braun J, Yao Y, Wang ZZ (2003) Regulation of acetylcholine receptor clustering by the tumor suppressor APC. Nat Neurosci 6:1017–1018.
112. Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993–5000.
113. Wehrli M, Dougan ST, Caldwell K, O’Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527–530.
114. Wu H, Xiong WC, Mei L (2010) To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137:1017–1033.
115. Wu H, Lu Y, Barik A, Joseph A, Taketo MM, Xiong WC, Mei L (2012a) β-Catenin gain of function in muscles impairs neuromuscular junction formation. Development 139:2392–2404.
116. Wu H, Lu Y, Shen C, Patel N, Gan L, Xiong WC, Mei L (2012b) Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation. Neuron 75:94–107.
117. Yumoto N, Kim N, Burden SJ (2012) Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. Nature 489:438–442.
118. Zhang B, Luo S, Dong XP, Zhang X, Liu C, Luo Z, Xiong WC, Mei L (2007) Beta-catenin regulates acetylcholine receptor clustering in muscle cells through interaction with rapsyn. J Neurosci 27:3968–3973.
119. Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, Mei L (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285–297.
120. Zhang B, Liang C, Bates R, Yin Y, Xiong WC, Mei L (2012a) Wnt proteins regulate acetylcholine receptor clustering in muscle cells. Mol Brain 5:7.
121. Zhang B, Tzartos JS, Belimezi M, Ragheb S, Bealmear B, Lewis RA, Xiong WC, Lisak RP, Tzartos SJ, Mei L (2012b) Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol 69:445–451.
122. Zhang B, Shen C, Bealmear B, Ragheb S, Xiong WC, Lewis RA, Lisak RP, Mei L (2014) Autoantibodies to agrin in myasthenia gravis patients. PLoS One 9:e91816.
123. Zhang W, Coldefy AS, Hubbard SR, Burden SJ (2011) Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK). J Biol Chem 286:40624–40630.
124. Zhu D, Yang Z, Luo Z, Luo S, Xiong WC, Mei L (2008) Muscle-specific receptor tyrosine kinase endocytosis in acetylcholine receptor clustering in response to agrin. J Neurosci 28:1688–1696.
125. Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mante-gazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, et al. (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139–145.
126. Zong Y, Zhang B, Gu S, Lee K, Zhou J, Yao G, Figueiredo D, Perry K, Mei L, Jin R (2012) Structural basis of agrin-LRP4-MuSK signaling. Genes Dev 26:247–258.